Get Free Delivery With No Minimum Order

MIKOSTAT ORAL SUSP
- Sku : I-003847
Key features
MIKOSTAT Oral Susp is an oral suspension containing the active ingredient nystatin 100,000 IU/mL. Nystatin binds to ergosterol in fungal cell membranes, forming pores that increase membrane permeability and cause leakage of intracellular contents leading to fungal cell death. It is indicated for the treatment of oral candidiasis (oropharyngeal thrush). Available by prescription as a 30 mL oral suspension.- Brand: MIKOSTAT
- Active Ingredient: NYSTATIN
- Strength: 100000IU/ml
- Dosage Form: Oral suspension
- Pack Size: 30 ml
- Route: Oral use
- Prescription Status: Prescription
- Therapeutic Class: Gastrointestinal
- Pharmacological Group: Antidiarrheals & Anti-inflammatory
- Drug Class: Polyene Antifungal
- Manufacturer: Gulf Pharmaceutical Industries (Julphar)
- Country of Origin: United Arab Emirates
- SFDA Registration No.: 1912234597
- Shelf Life: 24 months
- Storage: store below 25°c
- Application: Oral
Indications
Approved Uses
Treatment of oral candidiasis (oropharyngeal thrush).
Dosage & Administration
Dosing by Condition
Oral candidiasis: Adults/children: 400,000-600,000 IU (4-6 mL) PO four times daily (swish/retain then swallow); Infants: 200,000 IU (2 mL) PO four times daily; Premature/low-birth-weight neonates: 100,000 IU (1 mL) PO four times daily.
Initial Dose
400,000-600,000 units (4-6 mL) four times daily for adults with oral candidiasis.
Maintenance Dose
400,000-600,000 units (4-6 mL) four times daily for adults with oral candidiasis.
Maximum Dose
Up to 4,000,000 IU/day (typical adult maximum used for intestinal candidiasis; divided doses).
Children's Dosage
Neonates: 100,000 IU (1 ml) four times daily. Infants and children: 200,000-400,000 IU (2-4 ml) four times daily. Premature neonates: 50,000 IU (0.5 ml) four times daily
Dose Adjustment Notes
No dose adjustment is required in renal or hepatic impairment because systemic absorption is negligible.
How to Take
Shake well before each use; measure the dose with an oral syringe/measuring device; for oral candidiasis, distribute the dose around the mouth (e.g., half on each side), swish/retain in contact with lesions as long as possible, then swallow; continue therapy for at least 48 hours after symptoms resolve.
How to Prepare
Shake well before use (ready-to-use oral suspension).
Side Effects
Common Side Effects
Nausea, vomiting, diarrhea, abdominal pain/discomfort; oral irritation/unpleasant taste (occasionally).
Safety & Warnings
Contraindications
Hypersensitivity to nystatin or any component of the formulation.
Warnings & Precautions
Not effective for systemic fungal infections; ensure adequate contact time with oral mucosa (swish/retain in mouth before swallowing); discontinue if irritation or sensitization occurs; contains sucrose-use caution in diabetes and in patients with hereditary fructose intolerance/sucrose-isomaltase deficiency.
Age Restriction
No minimum age restriction; can be used in neonates, infants, children, and adults (dose/administration is age-appropriate).
Drug Interactions
Interaction Severity
No clinically significant drug-drug interactions are expected; if taken with Saccharomyces boulardii, nystatin may reduce the probiotic yeast’s viability (minor/avoid separating if possible).
Food Interaction
No clinically significant food interaction; for thrush, avoid eating or drinking for about 30 minutes after each dose to maximize mucosal contact time.
Special Populations
Children
Neonates: 100,000 IU (1 ml) four times daily. Infants and children: 200,000-400,000 IU (2-4 ml) four times daily. Premature neonates: 50,000 IU (0.5 ml) four times daily
Kidney Impairment
No renal dose adjustment needed.
Storage & Patient Advice
Preparation Instructions
Shake well before use (ready-to-use oral suspension).
Missed Dose
Take as soon as remembered; skip if near next dose. Do not take a double dose.
Stopping the Medicine
Continue for at least 48 hours after symptoms resolve (and complete the prescribed course); no taper is needed.
Overdose
Overdose is expected to cause mainly GI irritation (nausea, vomiting, diarrhea, abdominal pain); systemic toxicity is unlikely; management is supportive/symptomatic and seek medical care if large ingestion or severe symptoms.
Patient Counseling
Shake well; measure with an oral syringe/measuring device; place the dose around the mouth, swish/hold as long as possible then swallow; avoid eating/drinking for ~30 minutes after; complete the full course and continue at least 48 hours after symptoms resolve; store below 25°C (per SFDA) and do not freeze; seek care for rash, swelling, or persistent/worsening symptoms.
Monitoring Requirements
No routine laboratory monitoring; monitor clinical response, and if inadequate response/recurrence occurs, reassess adherence/technique and consider culture/susceptibility or alternative diagnosis.
Pharmacology
Mechanism of Action
Binds to ergosterol in fungal cell membranes, forming pores that increase membrane permeability and cause leakage of intracellular contents leading to fungal cell death.
Duration of Effect
Local effect persists only while the suspension remains in contact with oral mucosa; there is no meaningful systemic duration due to negligible absorption.
Half-Life
Not applicable (no meaningful systemic half-life due to negligible absorption).
Bioavailability
Negligible/insignificant oral bioavailability (not meaningfully absorbed from intact GI mucosa).
Metabolism
No clinically relevant systemic metabolism (acts locally; minimal absorption).
Excretion
Excreted almost entirely unchanged in feces.
Protein Binding
Not applicable (no meaningful systemic protein binding due to negligible absorption).
Product Information
Composition per Dose
Each 1 ml: 100,000 IU nystatin
Generic Availability
Yes
OTC Alternatives
No OTC alternative for oral thrush.
Application
Oral
Legal Disclaimer - Al Mujtama Pharmacy
The product information provided is derived from verified pharmaceutical references and is intended for general health education only. It is not a substitute for professional medical advice, diagnosis, or treatment.
Al Mujtama Pharmacy assumes no legal or medical liability for:
- Any therapeutic decision made based on the information displayed without consulting a licensed physician or pharmacist
- Any discrepancy between the information provided and the product's package insert or SFDA guidelines
- Any misuse of medication resulting from personal interpretation of the content displayed
Important notice: Drug formulations and instructions may vary between production batches. Always rely on the leaflet included inside the product packaging you have, and consult your pharmacist or physician before starting, adjusting, or discontinuing any medication.
By using this content, you acknowledge that you have read this disclaimer and agree that Al Mujtama Pharmacy bears no liability arising from reliance on this information as a substitute for direct medical consultation.
Your health is a trust - always consult your doctor first.
-1744229570.gif)



